| Affiliation: | 1. Department of Primary Care and Public Health, Imperial Centre for Cardiovascular Disease Prevention, Imperial College, London, UK;2. Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada;3. Department of Internal Medicine I, University Hospital Aachen, Aachen, Germany;4. Department of Endocrinology, l'institut du thorax, CHU Nantes, Nantes, INSERM, CNRS, UNIV Nantes, Nantes, France;5. University of Edinburgh, Edinburgh, UK;6. University of California San Diego School of Medicine and Center for Metabolic Research, Veterans Affairs, San Diego Healthcare System, San Diego, California;7. Department of Clinical Endocrinology and Nutrition (IBIMA), Hospital Virgen de la Victoria, University of Málaga, CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Instituto de Salud Carlos III, Málaga, Spain;8. Sanofi, Paris, France;9. Sanofi, Gentilly, France;10. Biostatistics and Programming Department, Sanofi, Chilly‐Mazarin, France;11. Regeneron Pharmaceuticals, Inc., Tarrytown, New York;12. Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy |
